Alto Neuroscience, Inc. Common Stock (ANRO)

Other Income/Expenses (Net)

-$128.69M

TTM · Period ending: · USD

ANRO logo

ANRO Other Income/Expenses (Net)

Latest reported-$128.69M
ANRO Other Income/Expenses (Net) ($2.87M → -$128.69M)
High-resolution chart · PNG

ANRO other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Alto Neuroscience, Inc. Common Stock Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
3,126,000
7,179,000
1,504,000
1,482,000
2,869,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.